cletoquine has been researched along with Libman-Sacks Disease in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amoura, Z; Combarel, D; Funck-Brentano, C; Lori, L; Noé, G; Seycha, A; Tissot, N; Zahr, N | 1 |
| Chung, YJ; Han, K; Ju, JH; Jung, SH; Kwok, SK; Lee, JY; Park, KS; Park, SH; Park, SW; Vinayagamoorthy, N | 1 |
| Hyeon Ju, J; Ki Kwok, S; Lee, J; Park, SH; Su Park, K; Yeon Lee, J | 1 |
| Adoue, D; Arlet, P; Blancher, A; Castex, JO; Fournie, B; Lapeyre-Mestre, M; Méliani, P; Montastruc, JL; Pourrat, J; Puissant, B; Sailler, L; Saivin, S | 1 |
4 other study(ies) available for cletoquine and Libman-Sacks Disease
| Article | Year |
|---|---|
Development and Validation of a Fast Ultra-High Performance Liquid Chromatography-Fluorescent Method for the Quantification of Hydroxychloroquine and Its Metabolites in Patients With Lupus.
Topics: Antirheumatic Agents; Calibration; Chloroquine; Chromatography, High Pressure Liquid; Drug Monitoring; Fluorescence; Humans; Hydroxychloroquine; Indicators and Reagents; Lupus Erythematosus, Systemic; Reproducibility of Results | 2019 |
Association of Polymorphisms of Cytochrome P450 2D6 With Blood Hydroxychloroquine Levels in Patients With Systemic Lupus Erythematosus.
Topics: Adult; Antirheumatic Agents; Asian People; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Female; Gene Frequency; Humans; Hydroxychloroquine; Lupus Erythematosus, Systemic; Male; Polymorphism, Genetic; Polymorphism, Single Nucleotide | 2016 |
Factors Related to Blood Hydroxychloroquine Concentration in Patients With Systemic Lupus Erythematosus.
Topics: Administration, Oral; Adult; Antirheumatic Agents; Chromatography, High Pressure Liquid; Cross-Sectional Studies; Drug Administration Schedule; Drug Monitoring; Female; Humans; Hydroxychloroquine; Lupus Erythematosus, Systemic; Male; Mass Spectrometry; Middle Aged; Severity of Illness Index; Treatment Outcome | 2017 |
Blood concentrations of hydroxychloroquine and its desethyl derivative correlate negatively with the percentage of CD45RO+ cells among CD4+ lymphocytes in hydroxychloroquine-treated lupus patients.
Topics: Adult; Antirheumatic Agents; CD4-Positive T-Lymphocytes; Cell Differentiation; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Female; Flow Cytometry; Humans; Hydroxychloroquine; Leukocyte Common Antigens; Lupus Erythematosus, Systemic; Lymphocyte Activation; Male; T-Lymphocyte Subsets | 2007 |